Job Recruitment Website - Job seeking and recruitment - Where is Jing Wei of Baoteng Biological Building?

Where is Jing Wei of Baoteng Biological Building?

Lou Jingwei of Baoteng Bio is from Jiangsu.

Dr Lou Jingwei is engaged in the clinical and basic research of hematological diseases under the guidance of famous hematological experts, Meng and Min Bihe. He is currently the chairman of Shanghai Baoteng Biomedical. Outstanding talents of the 5th "Zhangjiang Talents".

According to the information published on the Internet, Lou Jingwei has my nationality. He first entered the household in Nanjing, Jiangsu Province, which means he is from Jiangsu Province. Because of its excellent technical ability, it has permanent residency and doctoral degree in foreign countries, and has also worked hard to create Baoteng Biology that benefits the people.

Lou Jingwei's contribution

Successfully applied for the Overseas Youth Cooperation Fund of the National Natural Science Foundation, major basic research projects in Shanghai and national "863" key research projects. During my early years studying abroad, I was engaged in postdoctoral research in the National Medical Center of Hope City. After a series of major scientific breakthroughs, I began to embark on the road of returning to China to start a business.

He organized more than ten foreign scientists, and together with the technical elites of world-famous pharmaceutical and diagnostic enterprises, formed the scientific advisory group of the project. In August, 2008, Shanghai Baoteng Biomedical Technology Co., Ltd. was jointly founded by elites of market and capital operation, engaged in clinical molecular diagnosis, R&D outsourcing and research on drug and diagnostic reagent transformation.

The company has established R&D cooperation with many first-class experts at home and abroad, engaged in the research and development of new diagnosis and diagnostic kits. Building a molecular medical center with Nanjing No.1 Hospital and providing molecular diagnosis services in clinic will rapidly promote the research progress of individualized treatment in China.